Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Infinity Pharma Brasil is a leading distributor of pharmaceutical raw materials and active pharmaceutical ingredients (APIs) based in Brazil. The company specializes in supplying high-quality inputs to the compounding pharmacy market, as well as the human and veterinary pharmaceutical industries. Their portfolio includes a wide range of products such as nutraceuticals, dermocosmetics, and specialized chemical components. In 2022, the company was acquired by the Fagron Group, a global leader in pharmaceutical compounding, to strengthen its market position in Latin America.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Infinity Pharma Brasil.